🏛️ Verified NIH Record • Updated 2025-11-07
Pilocarpine Use After Kahook Goniotomy (NCT03933631)
🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Montefiore Medical Center
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (1 items) and avoid the listed exclusions (2 items).
Location: Montefiore Wakefield Campus — The Bronx, New York
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patients with previous history of eye surgeries (including laser procedures)
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (2 Sites)
- Montefiore Wakefield Campus — The Bronx, New York
- Montefiore Medical Center — The Bronx, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.